Cell Transplantation Clinical Trial
Official title:
Effects of Prescribed Physical Activity on Sleep and Performance in Hematopoietic Cell Transplantation Patients
This research trial studies prescribed physical activity in improving sleep and physical performance in patients undergoing stem cell transplant. A wearable physical activity monitor can be used to record minutes of activity and sleep. Gathering data over time using a physical activity monitor may help doctors learn if prescribed physical activity helps improve sleep and physical performance in patients undergoing stem cell transplant.
PRIMARY OBJECTIVES:
I. Evaluate whether prescribed physical activity, as part of standard care, improves sleep
and functional outcomes in hematopoietic cell transplantation (HCT) (stem cell
transplantation) patients during a typical 30-day hospitalization period.
OUTLINE:
Data including demographics, type of HCT (e.g., allogeneic or autologous), preexisting
physical conditions (e.g., chronic joint injury), chronic renal failure (CRF), steroid use
data, Eastern Cooperative Oncology Group (ECOG) and Karnofsky performance status (KPS) scores
are collected from patients' medical charts at time of enrollment. Patients are prescribed
participation in a primarily self-directed physical activity program which encourages them to
spend 6 hours out of bed daily and to perform 30 minutes of light-to-moderate daily aerobic
activity. Patients who are able to maintain independent mobility undergo physical therapist
assessment 2 times a week until hospital discharge. Patients wear a physical activity
monitoring device and daily activity and sleep data are collected continuously during
hospital length of stay (LOS).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03021681 -
An Exploratory Study on the Treatment of Chronic Obstructive Pulmonary Disease With Autologous Bronchial Basal Cell Transplantation
|
N/A | |
Recruiting |
NCT02890953 -
Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)
|
Phase 2 | |
Withdrawn |
NCT04428918 -
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
|